Aatmaj Healthcare Limited, operating under the **JTP Group of Hospitals** brand, is a prominent multi-specialty healthcare provider headquartered in Gujarat. With over **21 years** of operational experience, the company has transitioned from a private entity to a publicly traded corporation, listing on the **NSE Emerge** platform in **June 2023**. The group follows a **human-centric approach**, focusing on providing standardized medical care at affordable costs, primarily serving the **SME segment** and participating actively in the **PMJAY (Ayushman Bharat)** scheme. --- ### **Operational Scale and Hospital Network** The company has established a robust footprint across **Gujarat** and **Madhya Pradesh** through a combination of organic growth and strategic acquisitions. The group currently manages a total capacity of approximately **350–400 beds**. | Hospital Unit | Location | Capacity / Status | Key Features | | :--- | :--- | :--- | :--- | | **Jupiter Hospital** | Vadodara, Gujarat | Flagship Unit | Top 5 in Vadodara; Registered Office | | **JTP Sardar Patel Hospital** | Badnawar, MP | **150-Bed** Multi-Specialty | Operational since Nov 2023 | | **JTP Hospital Indore** | Indore, MP | **150-Bed** Multi-Specialty | Operational since May 2025 | | **Jambusar General Hospital** | Jambusar, Gujarat | **50-Bed** Multi-Specialty | Acquired Nov 2023 | | **Anand Hospital** | Gujarat | Integrated Jan 2026 | Strategic regional expansion | | **Regional Units** | Padra & Muval | Satellite Units | Regional accessibility | The medical team comprises **35+ Doctors** and a comprehensive staff of professional practitioners who have collectively treated **210,000+ patients** and performed over **18,500 surgeries**. --- ### **Clinical Specialties and Service Ecosystem** Aatmaj Healthcare provides a comprehensive range of medical and surgical solutions across **35+ specialties**, supported by advanced diagnostic infrastructure. * **Specialized Care Centers:** * **Cardiac Care:** Features an advanced **Cathlab** for interventional cardiology, **2D/3D Echo**, and **TMT (Treadmill Test)**. * **Diabetic Care:** End-to-end management of **Type 1, Type 2, and Gestational Diabetes**, including specialized diabetic foot care. * **Orthopedics & Trauma:** Dedicated **Joint Replacement Unit** and an **Advanced Trauma Care Unit** for emergency stabilization. * **Urology:** Comprehensive diagnostic and surgical solutions, including **minimally invasive procedures**. * **Maternal & Neonatal Care:** High-risk pregnancy management supported by a specialized **Neonatal Intensive Care Unit (NICU)**. * **Diagnostic & Support Infrastructure:** * **Imaging:** **3D & 4D USG/Sonography**, Doppler studies, and low-radiation **Digital X-Ray**. * **Critical Care:** High-end **ICUs** and **Modular Operation Theatres** with laminar flow technology. * **24/7 Services:** Round-the-clock **Pharmacy**, Pathology Laboratory, and Ambulance services staffed by paramedics. * **Patient Accommodation:** To ensure socio-economic inclusivity, the hospitals offer a tiered room structure including **Economy Wards** (optimized for **PMJAY** and insured patients), **Special Rooms**, and **Deluxe Rooms**. --- ### **Strategic Growth Verticals and Digital Transformation** The company is executing a multi-pronged strategy to diversify revenue streams and enhance operational efficiency. * **IVF Centers (Hub & Spoke Model):** Aatmaj is launching a new fertility vertical. A central **HUB** with advanced technology will support **4 to 6 Spike centers** (consultation units) within a **50-100 km** radius. Initial centers in **Karelibaug (Vadodara)** and **Jambusar** are slated for operation by **November 2025**. * **Wellness and Rehabilitation:** Development of the **"Well Being Forum,"** a dedicated Wellness and De-addiction Centre at the Vadodara unit to address mental health and rehabilitation. * **Digital Healthcare Platform:** Launching proprietary **Android and iOS** applications to facilitate **Telemedicine**, **Digital Medical Records (EMR)**, and **AI-driven diagnostics** for personalized post-operative care. * **Government Alignment:** The company is positioning itself to benefit from **Union Budget 2025** initiatives, including the **₹500 crore** allocation for **AI Centres of Excellence** and expanded rural broadband goals for **2030**. --- ### **Financial Performance and Capital Structure** Following its **₹38.40 Crore IPO**, the company’s paid-up capital stands at **₹11.30 Crore** (comprising **2.26 Crore equity shares** at a face value of **₹5/-** each). * **Revenue Growth:** Established units in **Vadodara and Jambusar** reported growth of **20%–25%** in FY 2024-25. * **Break-even Targets:** Operations in **Madhya Pradesh** are projected to reach financial break-even in **FY 2025-26**. * **Reallocation of Funds:** In May 2025, the company redirected **₹9.13 Crore** of unutilized IPO proceeds. Originally earmarked for equipment, these funds were reallocated toward **Working Capital** and the **acquisition/integration** of the Jambusar and Badnawar units to accelerate inorganic growth. * **PMJAY Strategy:** By integrating with the **Ayushman Bharat** scheme, the company ensures high patient inflow and reduces the need for traditional marketing spend, despite the fixed low-price caps of the program. --- ### **Corporate Governance and Executive Leadership** The company maintains leadership stability through long-term contracts for its founders, ensuring continuity during its expansion phase. * **Key Management:** **Dr. Tushar K. Suvagiya** (Managing Director) and **Mrs. Jignasa T. Suvagiya** (Whole-time Director). * **Remuneration Benchmarks:** Revised compensation for the MD is set at up to **₹5,00,000 per month**, effective through **December 2027**. * **Financial Safeguards:** Compensation structures include **"Minimum Remuneration"** clauses as per **Schedule V of the Companies Act, 2013**, protecting leadership continuity even in periods of inadequate profits. --- ### **Risk Assessment and Mitigation** Investors should monitor the following risk factors associated with the company’s aggressive expansion and regulatory environment: * **Strategic Pivot Risk:** The frequent variation in the **Objects of the Issue** (reallocating IPO funds) suggests a shift in strategy that may introduce execution risks compared to the original prospectus. * **Liquidity and Receivables:** The company faces potential challenges in the **period of recovery** from debtors. While auditors confirm the ability to meet liabilities for the next **12 months**, long-term viability depends on the successful realization of these receivables. * **Regulatory Sensitivity:** As a heavy participant in government schemes, the company is highly sensitive to changes in **PMJAY pricing** and broader **Government Healthcare Policies**. * **Operational Risks:** These include the management of event-related casualties and the inherent risks of maintaining high-end medical equipment across geographically dispersed units. | Risk Category | Mitigation/Status | | :--- | :--- | | **Capital Deployment** | Shareholder approval obtained via **Special Resolution** for fund reallocation. | | **Short-term Solvency** | Deemed capable of meeting all liabilities due within **one year**. | | **Market Volatility** | Diversification into **IVF** and **Medical Tourism** to balance PMJAY exposure. |